Blog
RSS FeedPosted by Michael Wonder on 01 Nov 2020
John Ivison: The math of saving lives — Canada's drug battle leaves patients caught in the middle
31 October 2020 - By cold mathematics, spending $1.3 billion to transform the lives of 3,700 Canadians might seem a ...
Posted by Michael Wonder on 27 Oct 2020
Sales of cancer medicines in Canada nearly tripled over the past decade
27 October 2020 - Today, the PMPRB, under the National Prescription Drug Utilization Information System (NPDUIS) initiative, released a chartbook ...
Posted by Michael Wonder on 27 Oct 2020
Mavenclad (cladribine tablets) is available through public drug plans for the majority of eligible Canadians with relapsing-remitting multiple sclerosis
27 October 2020 - EMD Serono is pleased to announce that eligible patients have access to Mavenclad (cladribine tablets) through ...
Posted by Michael Wonder on 24 Oct 2020
Health Canada releases final version of controversial regulations for controlling drug prices
23 October 2020 - After months of delay, Health Canada has released a final version of new regulations that are ...
Posted by Michael Wonder on 22 Oct 2020
Nexplanon recommended after second submission
22 October 2020 - The first submission was withdrawn. ...
Posted by Michael Wonder on 22 Oct 2020
CADTH in favour of new indication for Soliris
22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...
Posted by Michael Wonder on 22 Oct 2020
Patients, health organisations band together to bring breakthrough treatments to Canada sooner
21 October 2020 - Thirteen health charities and patient groups are calling on the Canadian government to improve access to ...
Posted by Michael Wonder on 21 Oct 2020
Canadian baby with spinal muscular atrophy to get ‘world’s most expensive drug’
20 October 2020 - A little over a year ago, the idea of raising US$2.125 million to receive the “world’s ...
Posted by Michael Wonder on 20 Oct 2020
Health charities and patient groups join together to protect access to breakthrough medical treatments in Canada
19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices ...
Posted by Michael Wonder on 11 Oct 2020
Rapid qualitative evidence syntheses in health technology assessment: experiences, challenges, and lessons
9 October 2020 - Health care decision makers are increasingly demanding that health technology assessment is patient focused, and considers data ...
Posted by Michael Wonder on 06 Oct 2020
Next-generation wet AMD therapy Beovu, now available in Canada, receives positive recommendation from CADTH Drug Expert Committee
5 October 2020 - Positive recommendation by CADTH speaks to evidence and clinical benefit of Beovu. ...
Posted by Michael Wonder on 04 Oct 2020
Ruzurgi now available to Canadian Lambert-Eaton myasthenic syndrome patients
25 September 2020 - Médunik Canada is extremely pleased to announce that its new orphan disease product Ruzurgi (amifampridine) is now ...
Posted by Michael Wonder on 02 Oct 2020
Patients, users, caregivers, and citizens' involvement in local health technology assessment unit in Quebec: a survey
29 September 2020 - The aim of the survey was to provide an overview of local health technology assessment unit practices ...
Posted by Michael Wonder on 01 Oct 2020
New procedures for CADTH drug reimbursement reviews
30 September 2020 - CADTH initiated stakeholder consultations in June 2020 on proposals to align the procedure for its drug ...
Posted by Michael Wonder on 24 Sep 2020
Bausch Health announces Vyzulta (latanoprostene bunod 0.024% ophthalmic solution) is now approved in seven countries
24 September 2020 - Recent access wins also make Vyzulta available to more Americans and Canadians. ...